Industry Updates
Food and Drug Administration:
- FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy: FDA Safety Communication
- Early Alert: Solution Set Issue from Baxter Healthcare Corporation
- Early Alert: Fluid Delivery Set Issue from Medline
- Early Alert: Extracorporeal Blood Circuit Issue from Nuwellis
- 2024 Medical Device Recalls